Posted by Michael Wonder on 16 Nov 2020
EMA starts rolling review of mRNA COVID-19 vaccine by Moderna Biotech Spain
16 November 2020 - EMA’s CHMP has started a ‘rolling review’ of data on a vaccine for COVID-19 known as mRNA-1273, which is being developed by Moderna Biotech Spain.
The CHMP’s decision to start the rolling review of mRNA-1273 is based on preliminary results from non-clinical studies and early clinical studies in adults which suggest that the vaccine triggers the production of antibodies and T cells (cells of the immune system, the body’s natural defences) that target the virus.
